Snack foods and sweet treats have seen a decline in purchases, as people reach for more nutrient-dense options.
Ozempic being a household name, GLP-1 receptor agonists (GLP-1RAs), a class of medications have garnered significant ...
With with GLP-1 drugs, gastrointestinal issues, such as nausea, vomiting, constipation, and gastroesophageal reflux disease, ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
Explore how GLP-1 agonists, originally for diabetes, could transform addiction treatment by reducing cravings.
FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly ...
Hims & Hers’ decision to advertise at the Super Bowl represents an ambitious play for the brand as it positions itself in the ...
In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...
A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...
LEXX READ THE FULL LEXX RESEARCH REPORT Lexaria Bioscience Corporation (NASDAQ:LEXX) reported fiscal first quarter 2025 ...